Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.122 USD | -0.27% | +2.01% | +9.92% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.92% | 17.38M | |
+37.74% | 723B | |
+34.31% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.15% | 244B | |
+9.73% | 208B | |
-4.29% | 205B | |
+2.81% | 168B |
- Stock Market
- Equities
- AYTU Stock
- News Aytu BioPharma, Inc.
- Aytu Biopharma, Inc. Announces Resignation of Steven J. Boyd as a Members of the Board of Directors